NO20052992L - Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom. - Google Patents
Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.Info
- Publication number
- NO20052992L NO20052992L NO20052992A NO20052992A NO20052992L NO 20052992 L NO20052992 L NO 20052992L NO 20052992 A NO20052992 A NO 20052992A NO 20052992 A NO20052992 A NO 20052992A NO 20052992 L NO20052992 L NO 20052992L
- Authority
- NO
- Norway
- Prior art keywords
- liver disease
- diagnosis
- protein
- molecular weight
- decomposition product
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 102000004169 proteins and genes Human genes 0.000 title abstract 6
- 208000019423 liver disease Diseases 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title 2
- 239000003550 marker Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000000354 decomposition reaction Methods 0.000 abstract 3
- 230000035622 drinking Effects 0.000 abstract 2
- 102000005666 Apolipoprotein A-I Human genes 0.000 abstract 1
- 108010059886 Apolipoprotein A-I Proteins 0.000 abstract 1
- 102000009081 Apolipoprotein A-II Human genes 0.000 abstract 1
- 108010087614 Apolipoprotein A-II Proteins 0.000 abstract 1
- 108010026552 Proteome Proteins 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 229940106780 human fibrinogen Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/75—Fibrin; Fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Endoscopes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
SAMMENDRAG Ved anvendelse av protein-chip teknologi, kan biologiske prøver slik som sera underlegges proteomanalyse. Følgelig er det nylig funnet et protein som er et humant fibrinogen (-E kjede nedbrytningsprodukt og har en molekylvekt på 5,900, et protein som er et apolipoprotein AII nedbrytningsprodukt og har en molekylvekt på 7,800 og et protein som er et apolipoprotein AI nedbrytningsprodukt og har en molekylvekt på 28,000, som hver viser en økning eller en reduksjon med drikkevanene. Ved å detektere eller kvantifisere disse proteinene, kan en leversykdom i et subjekt slik som et som har et problem med hensyn til drikking diagnostiseres på et tidlig stadium.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002371959 | 2002-12-24 | ||
PCT/JP2003/016600 WO2004058966A1 (ja) | 2002-12-24 | 2003-12-24 | 肝臓疾患診断用マーカー蛋白質およびそれを利用した肝臓疾患診断方法 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20052992D0 NO20052992D0 (no) | 2005-06-17 |
NO20052992L true NO20052992L (no) | 2005-09-14 |
NO336459B1 NO336459B1 (no) | 2015-08-31 |
Family
ID=32677218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052992A NO336459B1 (no) | 2002-12-24 | 2005-06-17 | Markørproteiner og in vitro metoder for diagnostisering av leversykdom og metoder for måling av protein. |
Country Status (9)
Country | Link |
---|---|
US (2) | US7517951B2 (no) |
EP (1) | EP1577385B1 (no) |
JP (1) | JP4196948B2 (no) |
CN (1) | CN100384996C (no) |
AT (1) | ATE462001T1 (no) |
AU (1) | AU2003296085A1 (no) |
DE (1) | DE60331857D1 (no) |
NO (1) | NO336459B1 (no) |
WO (1) | WO2004058966A1 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4597741B2 (ja) * | 2005-03-31 | 2010-12-15 | 株式会社Mcbi | タンパク質、部分タンパク質および/もしくは部分ペプチド、またはそれらのプロファイルに基づく体外診断システム |
FR2893136A1 (fr) * | 2005-11-10 | 2007-05-11 | Sanofi Aventis Sa | Procedes de diagnostic de maladies hepatiques et de criblage de molecules pour le traitement de ces maladies |
US7750018B2 (en) * | 2006-12-06 | 2010-07-06 | Tactical Therapeutics, Inc | Use of carboxiamidotriazole (CAI) orotate in macular degeneration |
JP5419680B2 (ja) * | 2007-02-28 | 2014-02-19 | 日東紡績株式会社 | アルコール性肝障害診断用マーカーペプチドおよびそれを利用したアルコール性肝障害診断方法 |
JP2009114092A (ja) * | 2007-11-02 | 2009-05-28 | Mcbi:Kk | 慢性肝炎、肝硬変、肝がんの分別診断のための新規バイオマーカーおよび該バイオマーカーを用いた慢性肝炎、肝硬変、肝がんの分別診断方法 |
EP2342569A4 (en) * | 2008-08-28 | 2012-07-04 | Salutria Pharmaceuticals Llc | SCREENING PROCEDURE FOR IDENTIFYING RISK PAPERS FOR UNWANTED HEPATOLOGICAL EVENTS |
JP2010175452A (ja) * | 2009-01-30 | 2010-08-12 | Japan Health Science Foundation | 膵臓癌の検出法 |
WO2011052380A1 (ja) | 2009-10-28 | 2011-05-05 | 日東紡績株式会社 | 5.9kDaペプチドの免疫学的測定方法 |
CN102507941B (zh) * | 2011-10-25 | 2014-04-30 | 北京正旦国际科技有限责任公司 | 一种肝硬化免疫质谱检测试剂盒 |
CN102507936B (zh) * | 2011-11-09 | 2013-10-23 | 北京正旦国际科技有限责任公司 | 一种肝癌标志物多抗免疫质谱试剂盒 |
JP6059735B2 (ja) * | 2011-12-01 | 2017-01-11 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 脳卒中診断のためのNT−proANP及びNT−proBNP |
WO2013141092A1 (ja) * | 2012-03-21 | 2013-09-26 | Tsuru Michiyo | 癌転移マーカー及びそれを用いた癌転移の診断方法 |
CN109444405A (zh) * | 2018-10-10 | 2019-03-08 | 东南大学 | 一种基于荧光预猝灭和表面增强荧光效应的免疫检测方法 |
CN110157792A (zh) * | 2019-04-22 | 2019-08-23 | 中山大学孙逸仙纪念医院 | 血清外泌体has_circ_0004771在制备酒精依赖综合征诊断试剂中的应用 |
CN116041506B (zh) * | 2023-01-05 | 2023-12-05 | 深圳上泰生物工程有限公司 | 糖缺失性转铁蛋白的单克隆抗体对及检测试剂盒 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63237795A (ja) | 1987-03-24 | 1988-10-04 | Otsuka Pharmaceut Factory Inc | アポリポタンパク質の製造法 |
WO1994016085A2 (en) | 1992-12-30 | 1994-07-21 | Zymogenetics, Inc. | Hybrid proteins having cross-linking and tissue-binding activities |
US5639940A (en) * | 1994-03-03 | 1997-06-17 | Pharmaceutical Proteins Ltd. | Production of fibrinogen in transgenic animals |
DE60129314T2 (de) * | 2000-04-28 | 2008-07-17 | Bayer Ag | Diagnose von leberfibrose mit hilfe von serummarkeralgorithmen |
CN1170943C (zh) * | 2000-10-20 | 2004-10-13 | 上海医药(集团)总公司 | 建立载脂蛋白a-i细胞靶标筛药系统及筛选升高密度脂蛋白药的方法 |
ES2226549B1 (es) | 2002-12-18 | 2006-07-16 | One Way Liver Genomics, S.L. | Metodo para el diagnostico de esteatohepatitis no alcoholica (nash) mediante el empleo de marcadores moleculares. |
-
2003
- 2003-12-24 AT AT03786267T patent/ATE462001T1/de not_active IP Right Cessation
- 2003-12-24 US US10/538,916 patent/US7517951B2/en active Active
- 2003-12-24 JP JP2004562919A patent/JP4196948B2/ja not_active Expired - Lifetime
- 2003-12-24 CN CNB2003801075522A patent/CN100384996C/zh not_active Expired - Lifetime
- 2003-12-24 WO PCT/JP2003/016600 patent/WO2004058966A1/ja active Application Filing
- 2003-12-24 AU AU2003296085A patent/AU2003296085A1/en not_active Abandoned
- 2003-12-24 EP EP03786267A patent/EP1577385B1/en not_active Expired - Lifetime
- 2003-12-24 DE DE60331857T patent/DE60331857D1/de not_active Expired - Lifetime
-
2005
- 2005-06-17 NO NO20052992A patent/NO336459B1/no not_active IP Right Cessation
-
2009
- 2009-03-04 US US12/379,904 patent/US7781180B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NO20052992D0 (no) | 2005-06-17 |
DE60331857D1 (de) | 2010-05-06 |
CN1732261A (zh) | 2006-02-08 |
US20090275059A1 (en) | 2009-11-05 |
US20060116504A1 (en) | 2006-06-01 |
EP1577385A4 (en) | 2006-08-23 |
NO336459B1 (no) | 2015-08-31 |
WO2004058966A1 (ja) | 2004-07-15 |
CN100384996C (zh) | 2008-04-30 |
EP1577385A1 (en) | 2005-09-21 |
EP1577385B1 (en) | 2010-03-24 |
AU2003296085A1 (en) | 2004-07-22 |
ATE462001T1 (de) | 2010-04-15 |
US7781180B2 (en) | 2010-08-24 |
JP4196948B2 (ja) | 2008-12-17 |
US7517951B2 (en) | 2009-04-14 |
JPWO2004058966A1 (ja) | 2006-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052992D0 (no) | Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom. | |
Ramsøe et al. | DeamiDATE 1.0: Site-specific deamidation as a tool to assess authenticity of members of ancient proteomes | |
DE69941085D1 (de) | Manipulierte proteine zum analyten nachweis | |
WO2007061793A3 (en) | Modified cardiolipin and uses therefor | |
EP2287618A3 (en) | Method for diagnosing neuro-degenerative disease | |
DK0943097T3 (da) | Fremgangsmåde til at påvise IgE | |
DE602004001227D1 (de) | Nukleinsäure-biosensor | |
DE602004022575D1 (de) | Verfahren zum selektiven testen von adiponectinmultimeren | |
IL175692A0 (en) | Method for diagnosing diseases based on levels of anti-glycan antibodies | |
BR0314155A (pt) | Métodos para diagnosticar câncer cervical | |
WO2006004958A3 (en) | Detection or measurement of antibodies to antigenic proteins in biological tissues or samples | |
ATE520033T1 (de) | Neurotoxische aminosäure oder neurotoxisches derivat davon in zusammenhang mit neurologischen erkrankungen | |
ATE513851T1 (de) | Menschliches gen zur fruchtbarkeit entscheidend | |
Nogueira et al. | Ancient enamel peptides recovered from the South American Pleistocene species Notiomastodon platensis and Myocastor cf. coypus | |
WO2005102938A3 (en) | Antibodies specific for bcr-abl fusion protein and uses thereof | |
DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
DK1051491T3 (da) | Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf | |
ATE433463T1 (de) | Monospezifische antikörper gegen fibrinogen und fibrinopeptide b | |
ATE259505T1 (de) | Test zur quantifizierung von arthritiszustanden | |
WO2003099107A3 (en) | Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient | |
ATE461452T1 (de) | Verfahren zum nachweis von menschlichem parvovirus-antigen | |
ATE410679T1 (de) | Verfahren zur identifikation von antivirale substanzen | |
ATE481498T1 (de) | Verfahren zur messung von neprilysinaktivität | |
SE0102220D0 (sv) | Method for estimation of the amount of specific cell types | |
DK1423708T3 (da) | Sammensætninger og fremgangsmåder til bestemmelser af AA4RP |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |